Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-15T07:50:49.079Z Has data issue: false hasContentIssue false
  • English
  • Français

Future Aspects of Cancer Treatment: The Use of Monoclonal Antibodies

Published online by Cambridge University Press:  10 March 2009

Håkan Mellstedt
Håkan Mellstedt
Affiliation:
Radiumhemmet and Department of Medical Radiobiology, Karolinska Hospital, Stockholm, Sweden
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Emerging Technology
Information
International Journal of Technology Assessment in Health Care , Volume 1 , Issue 4 , October 1985 , pp. 921 - 926
Copyright
Copyright © Cambridge University Press 1985

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Köhler, G., & Milstein, C.Continuous cultures of fused cells secreting antibody of pre-defined specificity. Nature, 1975, 256, 495–497.CrossRefGoogle Scholar
2.Miller, R. A., Maloney, D. C, Varnke, R., & Levy, R.Treatment of B cell lymphoma with monoclonal anti-idiotype antibody. New England Journal of Medicine, 1982, 306, 517–522.CrossRefGoogle ScholarPubMed
3.Koprowski, H., & Herlyn, M. Human tumor antigens. In Wahren, B. (ed.), Progress in cancer research. New York: Raven Press, 1985, 123–139.Google Scholar
4.Schroff, R. W., Farrell, M. M., Klein, R. A., Oldham, R. H., & Foon, K. A.T65 antigen modulation in phase I monoclonal antibody trial with chronic lymphocytic leukemia patients. Journal of Immunology, 1984, 133, 1641–1648.CrossRefGoogle ScholarPubMed
5.Stevenson, F. K., Glennie, M. J., Johnston, D. M. M., Tutt, A. L., & Stevenson, G. T.Consumption of monoclonal anti-idiotypic antibody by neoplastic B lymphocytes: A guide for immunotherapy. British Journal of Cancer, 1984, 50, 407–413.CrossRefGoogle ScholarPubMed
6.Oldham, R. H., Morgan, A. C., Woodhouse, C. S., Schroff, R. W., Abrams, P. G., & Foon, K. A.Monoclonal antibodies in the treatment of cancer: Preliminary observations and future prospect. Medical Oncology & Tumour Pharmacotherapy, 1984, 1, 51–62.CrossRefGoogle Scholar
7.Koprowski, H. Mouse monoclonal antibodies in vivo. In Boss, V. D., Langman, R., Trowbridge, I., & Dulbecco, R. (eds.), Monoclonal antibodies in cancer. New York: Academic Press, 1983, 17–37.Google Scholar
8.Hamblin, T. J., Abdul-Ahad, A. K., Gordon, J., Stevenson, F. K., & Stevenson, G. T.Preliminary experience in treating lymphocytic leukemia with antibody to immunoglobulin idiotypes on the cell surfaces. British Journal of Cancer, 1980, 42, 495–502.CrossRefGoogle ScholarPubMed
9.Steplewski, Z., Lubeck, M. D., & Koprowski, H.Human macrophages armed with murine immunoglobulin G2a antibodies to tumors destroy human cancer cells. Science, 1983, 221, 865–867.CrossRefGoogle ScholarPubMed
10.Akiyama, Y., Lubec, M. D., Steplewski, Z., & Koprowski, H.Induction of mouse IgG2a – and IgG3-dependent cellular cytotoxicity in human monocytic cells. (U937) by immune interferon. Cancer Research, 1984, 44, 5127–5131.Google ScholarPubMed
11.Koprowski, H., Herlyn, D., Lubec, M. D., DeFreitas, E., & Sears, H. F.Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response is beneficial for the patient? Proct Natl Acad Set, 1984, 81, 216–219.CrossRefGoogle ScholarPubMed
12.Berd, D., Mastrangelo, M. J., Engström, T. F., Paul, A., & Maguire, H.Augmentation of the human immune response by cyclophosphamide. Cancer Research, 1982, 42, 4862–4862.Google ScholarPubMed
13.Uhr, J.Immunotoxins: Harnessing nature's poisons. Journal Immunology, 1984, 133, i–x.CrossRefGoogle ScholarPubMed
14. A report from the Hammersmith Oncology Group and the Imperial Cancer Research Fund: Antibody-guided irradiation of malignant lesions: Three cases illustrating a new method of treatment. The Lancet, 1984, i, 1441–1443.CrossRefGoogle Scholar